SHAINA ADELMAN: Open Payments
NPI 1518505650 · KEW GARDENS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 13 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $20 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $62 |
| Stemline Therapeutics Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| pharmaand GmbH | 2 | $22 |
| Verastem, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: ERLEADA, Orserdu, Nubeqa, VPRIV, Rubraca, AVMAPKI FAKZYNJA CO-PACK, TAGRISSO.
Industry payments across NY — which companies pay providers there.
